167 related articles for article (PubMed ID: 11861796)
1. Predominance of delta-opioid-binding sites in the porcine enteric nervous system.
Townsend D; Brown DR
J Pharmacol Exp Ther; 2002 Mar; 300(3):900-9. PubMed ID: 11861796
[TBL] [Abstract][Full Text] [Related]
2. Characterization of specific opioid binding sites in neural membranes from the myenteric plexus of porcine small intestine.
Townsend D; Portoghese PS; Brown DR
J Pharmacol Exp Ther; 2004 Jan; 308(1):385-93. PubMed ID: 14569065
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of a 7-benzylidenenaltrexone-preferring opioid receptor in porcine ileal submucosa.
Townsend DW; Brown DR
Br J Pharmacol; 2003 Oct; 140(4):691-700. PubMed ID: 14534152
[TBL] [Abstract][Full Text] [Related]
4. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.
Ko MC; Lee H; Harrison C; Clark MJ; Song HF; Naughton NN; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2003 Jul; 306(1):179-86. PubMed ID: 12676881
[TBL] [Abstract][Full Text] [Related]
5. Characterization of specific delta-opioid binding sites in the distal small intestine of swine.
Townsend D; Brown DR
Eur J Pharmacol; 2003 Dec; 482(1-3):111-6. PubMed ID: 14660011
[TBL] [Abstract][Full Text] [Related]
6. Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity.
Fang L; Knapp RJ; Horvath R; Matsunaga TO; Haaseth RC; Hruby VJ; Porreca F; Yamamura HI
J Pharmacol Exp Ther; 1994 Feb; 268(2):836-46. PubMed ID: 8113996
[TBL] [Abstract][Full Text] [Related]
7. Characterization of mu, kappa, and delta opioid binding in amphibian whole brain tissue homogenates.
Newman LC; Sands SS; Wallace DR; Stevens CW
J Pharmacol Exp Ther; 2002 Apr; 301(1):364-70. PubMed ID: 11907194
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of opioid receptors involved in modulating circular and longitudinal muscle contraction in the rat ileum.
Gray AC; White PJ; Coupar IM
Br J Pharmacol; 2005 Mar; 144(5):687-94. PubMed ID: 15678085
[TBL] [Abstract][Full Text] [Related]
9. The effects of aging on mu and delta opioid receptors in the spinal cord of Fischer-344 rats.
Hoskins DL; Gordon TL; Crisp T
Brain Res; 1998 Apr; 791(1-2):299-302. PubMed ID: 9593954
[TBL] [Abstract][Full Text] [Related]
10. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
11. Opioid binding sites in the guinea pig and rat kidney: radioligand homogenate binding and autoradiography.
Dissanayake VU; Hughes J; Hunter JC
Mol Pharmacol; 1991 Jul; 40(1):93-100. PubMed ID: 1649966
[TBL] [Abstract][Full Text] [Related]
12. Characterization of opioid receptors on smooth muscle cells from guinea pig stomach.
Zhang L; Gu ZF; Pradhan T; Jensen RT; Maton PN
Am J Physiol; 1992 Mar; 262(3 Pt 1):G461-9. PubMed ID: 1312793
[TBL] [Abstract][Full Text] [Related]
13. Solubilization of high-affinity, guanine nucleotide-sensitive mu-opioid receptors from rat brain membranes.
Weems HB; Chalecka-Franaszek E; Côté TE
J Neurochem; 1996 Mar; 66(3):1042-50. PubMed ID: 8769865
[TBL] [Abstract][Full Text] [Related]
14. Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain.
Rothman RB; Bykov V; de Costa BR; Jacobson AE; Rice KC; Brady LS
Peptides; 1990; 11(2):311-31. PubMed ID: 2162533
[TBL] [Abstract][Full Text] [Related]
15. Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors.
Kathmann M; Flau K; Redmer A; Tränkle C; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2006 Feb; 372(5):354-61. PubMed ID: 16489449
[TBL] [Abstract][Full Text] [Related]
16. Characterization of opioid receptors in intestinal muscle cells by selective radioligands and receptor protection.
Kuemmerle JF; Makhlouf GM
Am J Physiol; 1992 Aug; 263(2 Pt 1):G269-76. PubMed ID: 1325129
[TBL] [Abstract][Full Text] [Related]
17. The in vitro pharmacological characterization of naloxone benzoylhydrazone.
Berzetei-Gurske IP; White A; Polgar W; DeCosta BR; Pasternak GW; Toll L
Eur J Pharmacol; 1995 Apr; 277(2-3):257-63. PubMed ID: 7493617
[TBL] [Abstract][Full Text] [Related]
18. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
Liu-Chen LY; Yang HH; Li S; Adams JU
J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological evidence for a 7-benzylidenenaltrexone-preferring opioid receptor mediating the inhibitory actions of peptidic delta- and mu-opioid agonists on neurogenic ion transport in porcine ileal mucosa.
Poonyachoti S; Portoghese PS; Brown DR
J Pharmacol Exp Ther; 2001 May; 297(2):672-9. PubMed ID: 11303057
[TBL] [Abstract][Full Text] [Related]
20. Functional interaction between alpha2-adrenoceptors, mu- and kappa-opioid receptors in the guinea pig myenteric plexus: effect of chronic desipramine treatment.
Canciani L; Giaroni C; Zanetti E; Giuliani D; Pisani R; Moro E; Trinchera M; Crema F; Lecchini S; Frigo G
Eur J Pharmacol; 2006 Dec; 553(1-3):269-79. PubMed ID: 17055479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
